TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Numeric Pain Intensity Rating from baseline to 10 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numeric Pain Intensity Rating from baseline to 52 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach 90% of the Steady State Serum Concentration of Posaconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Posaconazole in Bronchoalveolar Lavage (BAL) and Serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention Deficit Hyperactivity Rating Scale - IV (ADHD RS-IV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Fluency
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sociability
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Microbial product detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: efficiency of auditory teaching programme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Restless Legs Syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hemoglobin A1c (HbA1c) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physical Activity Scale For The Elderly score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: National Osteoporosis Foundation daily calcium intake scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain ratings
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Vibration sensation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Previously undiagnosed malignancy missed by malignancy screening
Endpoint domain: Mortality/survival
Primary endpoint: Brain Health Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Onset time of sciatic nerve blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fistula Healing rate at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fistula Healing Rate at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in the Right Lumbo-pelvic motor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in the Left Lumbo-pelvic motor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: American Orthopaedic Foot and Ankle Score (AOFAS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline Pain at 3 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in carbon dioxide elimination (VCO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Effectively Downstaged to Transplant Eligibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability of blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intact Parathormone (iPTH) Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area Under the Concentration-time Curve (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified shuttle walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change Scores in Timed up and go With Cognitive Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-hospital cardiac outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Implant complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Prosthesis complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in average NRS pain intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microvascular Insulin Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Hb Change From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: prematurity prevalence
Endpoint domain: Mortality/survival
Primary endpoint: Safety as assessed by adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Intra-Ocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normative Data for optic nerve head
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Normative Data for the peripapillary retinal nerve fiber layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Normative Data for the macula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Rating of Spontaneous Pelvic Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treg response to low dose IL2 induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Confidence Using a Wheelchair
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of home vaginal bio-specimen collections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HIV Infection free
Endpoint domain: Mortality/survival
Primary endpoint: changed in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: changes in LDL-cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite of Clinical Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxicity of ipilimumab and erlotinib
Endpoint domain: Adverse events/effects
Primary endpoint: toxicity of ipilimumab and crizotinib
Endpoint domain: Adverse events/effects
Primary endpoint: toxicity of nivolumab and erlotinib
Endpoint domain: Adverse events/effects
Primary endpoint: toxicity of nivolumab and crizotinib
Endpoint domain: Adverse events/effects
Primary endpoint: Effects of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymph node counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Risk of PCP infection
Endpoint domain: Adverse events/effects
Primary endpoint: Therapeutic tumor response phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of clinically relevant POPF (ISGPS grade B/C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Latency of N1/P1 complex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Latency of N2/P2 complex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amplitude of N1/P1 complex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amplitude of N2/P2 complex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: abnormalities of glucose metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in total interstitial disease score of pulmonary abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain Score on Visual Analogue Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to maintain adequate oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time taken to intubate a double-lumen tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: waist circumferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time profile of selexipag and ACT-333679 during a dose interval (AUC-tau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal plasma concentration of selexipag and ACT-333679 (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial injury incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk factors analysis for death
Endpoint domain: Mortality/survival
Primary endpoint: Periprocedural pain requiring narcotics
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in urinary osmolyte concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction of plaque index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupillary dilation lag
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Total Score of the Hamilton Depression Rating Scale (HAM-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Range of motion assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical Activity measured in METS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergent Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety laboratory values (including immunological testing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reading
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Orientation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: duration of a delay in asthma diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of LE Lean Muscle Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Loss of Bone Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Loss of Bone Mineral Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Accuracy of predicting histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Frailty Phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Pamiparib in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC From Time Zero to Time of Last Quantifiable Concentration Post-dose (AUC0-tlast) in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Elimination Half-life (t1/2) of Pamiparib in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Colon Preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean number of adenomas detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants Reporting Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in NRS (pain scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial glucose kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: macular retinal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macular retinal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With PONV-related Delay of Hospital Discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Quality of sentinel cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rate of preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: rate of hypertensive disorder during pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: rate of postpartum hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Pharmacodynamics of darexaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fractional De Novo Lipogenesis (DNL, %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver fat Fraction (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: participation rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Durable Complete Remission (dCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete pathologic response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Graft versus host disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: worst-ever LV ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: worst-ever maximum z score of the proximal LAD or RCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maternal parasitaemia at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: intestinal transit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Response rate of ACR20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of [18F]fluortriopride in D3-rich regions of the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Test-retest variability of [18F]fluortriopride uptake measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: WOMAC physical function subscale scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 30-s chair stand test [CST]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-m timed up and go test [TUG]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adenoma and Polyp Miss Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients achieving clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Training Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in PTSD Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in pulmonary arterial systolic pressure (PASP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence Rate of Hiatal Hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in the prevalence of prescribing errors
Endpoint domain: Adverse events/effects
Primary endpoint: IVC collapsibility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVC distensibility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IVC delta index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of inhaled ciprofloxacin
Endpoint domain: Adverse events/effects
Primary endpoint: Competence in pulse palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accrual and Attrition rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of completed questionnaires
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants With Any Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Any Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Any Vaccine-related Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Relative risk of benign breast disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Biologic activity of sorafenib in cervix cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Serious Treatment-emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Adverse Event of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Infusion-associated Reactions (IARs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incident cognitive impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Freedom from acute rejection
Endpoint domain: Mortality/survival
Primary endpoint: Kidney transplant loss
Endpoint domain: Mortality/survival
Primary endpoint: Delayed kidney transplant function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Death at 6 months after transplant
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with choline PET negative and sodium fluoride PET positive for bone extension (metastasis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Arterial pressure of CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in wound healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Difference in VO2 peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incident rate of delayed gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of IL-2 Treatments Tolerated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Global corticosteroid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Adipose tissue corticosteroid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepatic corticosteroid metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in SF-36 Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in CLDQ-HCV Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in 25(OH)D plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Vitamin D intake from foods and supplements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Surgeons' satisfaction with surgical education and training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Cumulus-oocyte-complexes Retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Participants Stopping Exercise Treadmill Test for Angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Community capacity to implement childhood obesity program
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Malaria Case Incidence
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Worst Grade 2 or Higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Reaction Times (RTs) for Picture Naming
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Participants With ≥3 Mean Weekly CSBMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of macroscopic complete remissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Measles Vaccination Coverage Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hepatic Fatty Acid Reesterification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hepatic Fatty Acid Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VLDL-TG Secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Whole Body Glucose Rd
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: urinary excretion of 14C-labeled risedronate and alendronate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes